Fortfahren mit
MAK306
LCFC-LCAT Acyltransferase Activity Assay
Supplied by Roar Biomedical, Inc., sufficient for 100 fluorometric tests
Anmelden zur Ansicht der Organisations- und Vertragspreise.
Größe auswählen
Ansicht ändern
| Packungsgröße | SKU | Verfügbarkeit | Preis |
|---|---|---|---|
| 1 kit | Warenkorb auf Verfügbarkeit prüfen | € 820,00 |
Über diesen Artikel
NACRES:
NA.84
UNSPSC Code:
12161503
Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhaltenusage
sufficient for 100 fluorometric tests
application(s)
pharmaceutical
detection method
fluorometric
relevant disease(s)
cardiovascular diseases
storage temp.
2-8°C
General description
The plasma protein lecithin:cholesterol acyltransferase (LCAT) catalyzes the transfer of an acyl group from the sn2 position of phosphatidylcholine to the 3-hydroxyl group of cholesterol forming cholesteryl ester. This activity occurs on the surface of high density lipoprotein (HDL) and the cholesteryl esters formed by LCAT are incorporated into the core of HDL.
Application
Suitable for high-throughput screening, mechanism of action studies and structureactivity relationship (SAR) work of LCAT in plasma and serum
Biochem/physiol Actions
The LCFC-LCAT Acyltransferase Activity Assay is a fluorometric assay useful for measuring the acyltransferase activity of LCAT in serum or plasma. The method detects changes in LCAT free cholesterol (LCFC) levels in the sample without the use of cholesterol oxidase, peroxidase, or the generation of hydrogen peroxide. Detection is not affected by iodoacetate or other LCAT inhibitors. LCAT activity results in a fluorometric (λEx = 320 nm/λEm = 405 nm) product proportional to the amount of free cholesterol present.
Features and Benefits
- Non-enzymatic determination of cholesteryl ester formation.
- Not affected by LCAT inhibitors or other chemical compounds.
- Dilution or non-dilution type assay.
- Assay components stable for up to one year.
- Compatible with high-throughput handling systems.
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| detection method fluorometric | detection method fluorometric | detection method fluorometric | detection method fluorometric |
| usage sufficient for 100 fluorometric tests | usage sufficient for 100 fluorometric tests | usage sufficient for 100 fluorometric tests | usage sufficient for 100 fluorometric tests |
| storage temp. 2-8°C | storage temp. 2-8°C | storage temp. 2-8°C | storage temp. 2-8°C |
| application(s) pharmaceutical | application(s) pharmaceutical | application(s) pharmaceutical | application(s) pharmaceutical |
| relevant disease(s) cardiovascular diseases | relevant disease(s) cardiovascular diseases | relevant disease(s) gastrointestinal diseases; cardiovascular diseases | relevant disease(s) cardiovascular diseases |
Lagerklasse
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
Chao Liu et al.
PloS one, 12(1), e0169939-e0169939 (2017-01-21)
Hypertriglyceridemia is an independent risk factor for cardiovascular disease. Apolipoprotein C-II (APOC2) is an obligatory cofactor for lipoprotein lipase (LPL), the major enzyme catalyzing plasma triglyceride hydrolysis. We have created an apoc2 knockout zebrafish model, which mimics the familial chylomicronemia
Deficient cholesterol esterification in plasma of apoc2 knockout zebrafish and familial chylomicronemia patients.
Liu C, et al.
PLoS ONE, 12(1), e0169939-e0169939 (2017)
Global Trade Item Number
| SKU | GTIN |
|---|---|
| MAK306-1KT | 04061834205487 |